Tvardi Therapeutics, Inc. (TVRD) — Defensive Interval Ratio
Tvardi Therapeutics, Inc. (TVRD) has a Defensive Interval Ratio of 166 days as of March 2026. Defensive assets of $5.13 Million (cash $-, short-term investments $5.13 Million, receivables $-) cover 166 days of daily cash needs of $30.84K/day. See Tvardi Therapeutics, Inc. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Tvardi Therapeutics, Inc. Defensive Interval Ratio (2020–2025)
This chart shows how Tvardi Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 166 days, meaning defensive assets of $5.13 Million can fund 166 days of operations without new revenue. See Tvardi Therapeutics, Inc. (TVRD) net asset quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Tvardi Therapeutics, Inc. (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Tvardi Therapeutics, Inc. from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Tvardi Therapeutics, Inc. market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 333 days | $10.08 Million | $30.25K/day | $- | $10.08 Million | ▼ -80 days |
| 2024 | 413 days | $4.50 Million | $10.88K/day | $- | $0.00 | ▼ -5483 days |
| 2023 | 5896 days | $53.00 Million | $8.99K/day | $- | $48.98 Million | ▲ +3617 days |
| 2022 | 2279 days | $26.70 Million | $11.72K/day | $- | $22.25 Million | ▼ -927 days |
| 2021 | 3206 days | $154.73 Million | $48.26K/day | $- | $153.58 Million | ▲ +218 days |
| 2020 | 2988 days | $151.31 Million | $50.64K/day | $- | $149.24 Million | — |